Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
4.000
-0.062 (-1.52%)
Aug 29, 2025, 9:40 AM - Market open
Genfit Market Cap
Genfit has a market cap or net worth of $202.32 million as of August 29, 2025. Its market cap has decreased by -4.58% in one year.
Market Cap
202.32M
Enterprise Value
179.40M
1-Year Change
-4.58%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since February 5, 2013, Genfit's market cap has increased from $103.68M to $202.32M, an increase of 95.13%. That is a compound annual growth rate of 5.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 203.92M | 11.74% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | 189.52M | -75.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |